103 related articles for article (PubMed ID: 20466201)
1. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
Mehran R; Brar S; Dangas G
J Am Coll Cardiol; 2010 May; 55(20):2210-1. PubMed ID: 20466201
[No Abstract] [Full Text] [Related]
2. N-acetylcysteine somewhere between Scylla and Charybdis.
Sochman J
J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
[No Abstract] [Full Text] [Related]
3. [Pathophysiology and prevention of contrast-induced acute renal failure].
Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine and contrast-induced nephropathy.
Balderramo DC
N Engl J Med; 2006 Oct; 355(14):1498-9; author reply 1499-500. PubMed ID: 17024740
[No Abstract] [Full Text] [Related]
5. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
Rizzato G
Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
[No Abstract] [Full Text] [Related]
6. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
[TBL] [Abstract][Full Text] [Related]
7. Multimodality prevention of contrast-induced acute kidney injury.
McCullough PA
Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
[No Abstract] [Full Text] [Related]
8. N-acetylcysteine in the prevention of contrast-induced nephropathy.
Fishbane S
Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M; Möller A; Wassmer G; Brunkwall J
Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
[TBL] [Abstract][Full Text] [Related]
10. [Management of renal complications during primary angioplasty].
Marenzi G; Marana I; Bartorelli A
Recenti Prog Med; 2007; 98(7-8):367-72. PubMed ID: 17685183
[TBL] [Abstract][Full Text] [Related]
11. N-Acetylcysteine for the prevention of renal dysfunction in high-risk patients undergoing coronary bypass graft surgery: an unfulfilled promise?
Filep JG
Crit Care Med; 2007 May; 35(5):1431-3. PubMed ID: 17446744
[No Abstract] [Full Text] [Related]
12. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
Petronilho F; Constantino L; de Souza B; Reinke A; Martins MR; Fraga CM; Ritter C; Dal-Pizzol F
Nephrol Dial Transplant; 2009 Jul; 24(7):2077-82. PubMed ID: 19204016
[TBL] [Abstract][Full Text] [Related]
14. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
Faddy SC
Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
[No Abstract] [Full Text] [Related]
15. N-acetylcysteine as a preventive measure for acute renal failure: a plea for more accurate detection of renal function in critically ill patients.
Schultz MJ
Crit Care Med; 2007 Jun; 35(6):1633-4. PubMed ID: 17522549
[No Abstract] [Full Text] [Related]
16. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
MacNeill BD; Harding SA; Bazari H; Patton KK; Colon-Hernadez P; DeJoseph D; Jang IK
Catheter Cardiovasc Interv; 2003 Dec; 60(4):458-61. PubMed ID: 14624421
[TBL] [Abstract][Full Text] [Related]
17. Pre-procedural blood glucose levels: a new risk marker for contrast-induced acute kidney injury in patients without diabetes with acute myocardial infarction.
Alpert MA; Carlino C
J Am Coll Cardiol; 2010 Apr; 55(14):1441-3. PubMed ID: 20359593
[No Abstract] [Full Text] [Related]
18. Can we prevent acute kidney injury?
Venkataraman R
Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
[TBL] [Abstract][Full Text] [Related]
19. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization.
Nunag M; Brogan M; Garrick R
Cardiol Rev; 2009; 17(6):263-9. PubMed ID: 19829174
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine for contrast nephropathy: more clinical science is required.
Eddleston M; Goddard J; Bateman N
Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
